BioRender 图标

Cardiomyocyte 2

Cardiomyocyte 2 - Editable icon of a rectangular cardiomyocyte with banded sarcomere striations and one nucleus
[{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4b7bb070bda/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4b7bb070bda/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c46da5070bd8/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c46da5070bd8/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c42ac9070bd7/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c42ac9070bd7/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4644a070bd6/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4644a070bd6/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c495a3070bd5/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c495a3070bd5/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c450a6070bd4/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c450a6070bd4/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4f645070bd3/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4f645070bd3/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c42b32070bd2/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c42b32070bd2/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c403b9070bd1/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c403b9070bd1/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4ec47070bd0/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4ec47070bd0/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4671d070bcf/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4671d070bcf/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4cbd7070bce/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4cbd7070bce/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c444fc070bcd/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c444fc070bcd/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c45d2b070bcc/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c45d2b070bcc/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c476f1070bcb/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c476f1070bcb/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4cfe5070bca/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4cfe5070bca/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c463b7070bc9/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c463b7070bc9/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c44fb4070bc8/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c44fb4070bc8/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4b0d8070bc7/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4b0d8070bc7/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c445f1070bc6/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c445f1070bc6/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c45c68070bc5/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c45c68070bc5/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c474aa070bc4/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c474aa070bc4/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4f9cf070bc3/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4f9cf070bc3/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c42452070bc2/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c42452070bc2/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c45e38070bc1/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c45e38070bc1/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c46561070bc0/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c46561070bc0/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c40217070bbf/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c40217070bbf/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c47853070bbe/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c47853070bbe/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4176d070bbd/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4176d070bbd/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c42223070bbc/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c42223070bbc/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c46870070bbb/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c46870070bbb/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c420a5070bba/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c420a5070bba/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c456ed070bb9/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c456ed070bb9/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c41c77070bb8/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c41c77070bb8/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c40445070bb7/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c40445070bb7/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c40c98070bb6/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c40c98070bb6/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c42675070bb5/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c42675070bb5/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c446d9070bb4/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c446d9070bb4/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4aea5070bb3/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4aea5070bb3/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c46db1070bb2/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c46db1070bb2/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c418d5070bb1/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c418d5070bb1/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c4765e070bb0/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c4765e070bb0/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c41e5d070baf/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c41e5d070baf/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c47faf070bae/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c47faf070bae/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c40235070bad/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c40235070bad/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c429da070bac/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c429da070bac/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c45fb2070bab/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c45fb2070bab/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c407c8070baa/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c407c8070baa/6529527932b65c28fd1be565.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529667f7fa8c48247070ba9/6529527932b65c28fd1be565.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529667f7fa8c48247070ba9/6529527932b65c28fd1be565.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
cardiomyocyte,heart,cardiac,cardio,smooth muscle,cardiac muscle,cardiac muscle cell,heart muscle,cardiac tissue,myocardium,involuntary,striated,intercalated disc,sarcomere,actin,myosin,troponin,t-tubule,myofibril,myofilament,cytoplasm,nucleus,cell membrane,contract,contraction,contractile,cardiomyopathy,heartbeat,heart contraction,heart rhythm,cardiac cycle,functional syncytium,action potential,excitation-contraction coupling,rectangular,healthy,adult,mature,isolated,lab research,in vitro,mammalian,human,rodent,mouse,rat,cardiovascular system,cardiovascular,circulatory system,cardiovascular physiology,cardiology,regenerative medicine,tissue engineering,cultured cardiomyocyte,cultured,mononucleated,cardiomyocyte
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Cardiomyocyte 2 icon JPEG

Cardiomyocyte 2 icon PNG

Cardiomyocyte 2 icon SVG

Cardiomyocyte 2 icon GIF

BioRender 图标常见问题解答

How are scientists using the Cardiomyocyte 2 icon in their work?

BioRender users often use the Cardiomyocyte 2 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Cardiomyocyte 2 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Cardiomyocyte 2 icon customizable in BioRender?

Most icons in BioRender, including the Cardiomyocyte 2 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Cardiomyocyte 2 icon for publication or presentations?

Yes, figures containing the Cardiomyocyte 2 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Cardiomyocyte 2 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Cardiomyocyte 2 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Cardiomyocyte 2 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon